HighTower Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $4.85M | Sell |
|
|||||
|
2023
Q1 | $4.45M | Sell |
|
|||||
|
2022
Q4 | $1.99M | Sell |
|
|||||
|
2022
Q3 | $1.41M | Buy |
|
|||||
|
2022
Q2 | $1.71M | Buy |
|
|||||
|
2022
Q1 | $1.79M | Sell |
|
|||||
|
2021
Q4 | $1.45M | Sell |
|
|||||
|
2021
Q3 | $5.94M | Sell |
|
|||||
|
2021
Q2 | $9.8M | Buy |
|
|||||
|
2021
Q1 | $5.88M | Sell |
|
|||||
|
2020
Q4 | $7.3M | Buy |
|
|||||
|
2020
Q3 | $5.34M | Buy |
|